Home > Insider Trading > Filing (0001179110-17-005577)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587070	Jaime Contreras	100 Abbott Park Road Abbott Park IL 60064	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares Without Par Value	Acquisiton	2017-03-31	1,126	$0.00	3,552	No	4	A	Indirect	By Spouse
Common Shares Without Par Value	Disposition	2017-03-31	375	$44.55	3,177	No	4	F	Indirect	By Spouse
Common Shares Without Par Value	Disposition	2017-03-31	767	$44.64	2,410	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Indirect	By Spouse
No	4	F	Indirect	By Spouse
No	4	S	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares Without Par Value	45,339	Direct
Common Shares Without Par Value	21	Indirect	Profit Sharing Trust
Common Shares Without Par Value	64,297	Indirect	Jaime Contreras Marvan 2006 Living Trust
Common Shares Without Par Value	12,081	Indirect	Living Trust (by spouse)

Footnotes

Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2017.
Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
This grant represents a restricted stock unit award under the Abbott Laboratories 2009 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniversary of the grant date. The award includes the right to have stock withheld for tax purposes.
The reporting person disclaims beneficial ownership of all securities held by his spouse.
Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.